Evidence map›Paper›PMID 21234661›Full record

ArticleJournal of fluorescence2011

Mechanisms of ceftazidime and ciprofloxacin transport through porins in multidrug-resistance developed by extended-spectrum beta-lactamase E.coli strains.

Beatrice Mihaela Radu, Mihaela Bacalum, Adela Marin, Carmen-Mariana Chifiriuc, Veronica Lazar, Mihai Radu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Beatrice Mihaela RaduDepartment of Anatomy, Animal Physiology and Biophysics, Faculty of Biology, University of Bucharest, Splaiul Independentei, 91-95, Bucharest 050095, Romania. beatrice_macri@yahoo.com
Mihaela Bacalum
Adela Marin
Carmen-Mariana Chifiriuc
Veronica Lazar
Mihai Radu
University of Bucharest · ROHoria Hulubei National Institute for R and D in Physics and Nuclear Engineering · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance towards antibiotics stands out today as a major issue in the clinical act of treatment of bacterial-generated infections. This process was characterized in proteoliposomes reconstituted from an E.coli strain isolated from invasive infections (blood culture) occurred in patients with a cardio-vascular device admitted for surgery. Fluorescence spectroscopy and patch-clamp technique have been used. Two types of antibiotics have been targeted: ceftazidime and ciprofloxacin. Antibiotics addition in proteoliposomes suspension undergoes a quenching in tryptophan residues from outer membrane porins structure, probably due to the formation of a transient non-fluorescent porin-antibiotic complex. Patch-clamp recordings revealed strong ion current blockages for both antibiotics, reflecting antibiotic-channel interactions but with varying strength of interaction. The present study puts forward the mechanism of multidrug-resistance in extended-spectrum beta-lactamase E.coli strains, as being caused by alterations of the antibiotics transport across the porins of the outer bacterial membrane.

Indexed as

beta-Lactamase InhibitorsAnti-Bacterial Agentsbeta-LactamasesBiological TransportCeftazidimeCiprofloxacinDrug Resistance, Multiple, BacterialEscherichia coliFluorescenceFluorescence Resonance Energy TransferHumansMicrobial Sensitivity TestsPorinsStructure-Activity RelationshipAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesCeftazidimeCiprofloxacinPorins

Identifiers

PMID21234661
OpenAlexW2057536744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.